Contact
searchSearch
HMP Global

Dermatology Topic Center

podcasts


Iltefat Hamzavi, MD
Podcasts
Reviewing the Benefit, Importance of a Vitiligo Treatment
08/28/2023
Iltefat Hamzavi, MD
Iltefat Hamzavi, MD, Department of Dermatology, Henry Ford Medical Center, discusses his recent research letter that addresses the benefits of ruxolitinib cream for the treatment of vitiligo, and highlights the clinically meaningful use of...
Iltefat Hamzavi, MD, Department of Dermatology, Henry Ford Medical Center, discusses his recent research letter that addresses the benefits of ruxolitinib cream for the treatment of vitiligo, and highlights the clinically meaningful use of...
Iltefat Hamzavi, MD, Department...
08/28/2023
First Report Managed Care
Headshot of David Rosmarin, Tufts, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
JAK Inhibitor Results in Skin Repigmentation in Patients With Vitiligo
05/30/2023
Maria Asimopoulos
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair of education and research, assistant professor, Tufts Medical Center, walks through findings from TRuE-V, a phase 3 program designed to investigate ruxolitinib's efficacy and safety in patients with vitiligo. 
David Rosmarin, MD, vice chair...
05/30/2023
First Report Managed Care
Headshot of Shawn Kwatra, MD, Johns Hopkins Itch Center, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
How Increased Market Competition May Impact Patients With Atopic Dermatitis
09/13/2022
Maria Asimopoulos
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, describes how the atopic dermatitis treatment paradigm has been changing amid increased market competition, as well as where the future of care may be headed.
Shawn Kwatra, MD, FAAD, director, Johns Hopkins Itch Center, describes how the atopic dermatitis treatment paradigm has been changing amid increased market competition, as well as where the future of care may be headed.
Shawn Kwatra, MD, FAAD,...
09/13/2022
First Report Managed Care
Headshot of Raj Chovatiya, Northwestern University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Addressing Social Determinants of Health to Improve Care for Patients With Atopic Dermatitis
06/23/2022
Maria Asimopoulos
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, offers insight into how social determinants of health affect care access and quality for patients with atopic dermatitis.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, offers insight into how social determinants of health affect care access and quality for patients with atopic dermatitis.
Raj Chovatiya, MD, PhD,...
06/23/2022
First Report Managed Care
Headshot of Raj Chovatiya, Northwestern University, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Reviewing Atopic Dermatitis Prevalence, Disease Severity's Impact on Patients
06/16/2022
Maria Asimopoulos
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, shares how severe atopic dermatitis impacts patients' quality of life, as well as what treatment challenges exist for this patient population.
Raj Chovatiya, MD, PhD, director, Center for Eczema and Itch, Northwestern University, shares how severe atopic dermatitis impacts patients' quality of life, as well as what treatment challenges exist for this patient population.
Raj Chovatiya, MD, PhD,...
06/16/2022
First Report Managed Care
Headshot of Vivian Shi, UAMS, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Topical Therapy Beneficial for Patients With Atopic Dermatitis
02/24/2022
Maria Asimopoulos
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, highlights clinical scenarios in which a topical treatment for atopic dermatitis may be most effective.
Vivian Shi, MD, FAAD, associate...
02/24/2022
First Report Managed Care
Headshot of Vivian Shi, UAMS, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Recently Approved Atopic Dermatitis Therapy Demonstrates Efficacy, Safety
02/15/2022
Maria Asimopoulos
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Vivian Shi, MD, FAAD, associate professor of dermatology, University of Arkansas for Medical Sciences, provides an overview of a recently approved treatment for atopic dermatitis.
Vivian Shi, MD, FAAD, associate...
02/15/2022
First Report Managed Care
Headshot of Gary Owens, MD, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
How Payers Can Use Clinical, Value Comparison Data for Atopic Dermatitis Therapy
09/24/2021
Edan Stanley
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Gary Owens, MD, president of Gary Owens Associates, shares his thoughts on the challenges of choosing treatment options for patients with atopic dermatitis, and highlights key takeaways for payers from a recent ICER report which compared the...
Gary Owens, MD, president of...
09/24/2021
First Report Managed Care
Weighing Benefits and Challenges to Effectively Treat Atopic Dermatitis
Podcasts
Weighing Benefits and Challenges to Effectively Treat Atopic Dermatitis
09/16/2020
Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...
Steven Feldman, MD, PhD, Wake Forest University School of Medicine, discusses the real-world effectiveness of dupilumab for the treatment of atopic dermatitis, how this data is relevant for payers, and stresses the importance of studying...
Steven Feldman, MD, PhD, Wake...
09/16/2020
First Report Managed Care
Discussing Effectiveness, Persistence Rates for Atopic Dermatitis Therapy
Podcasts
Discussing Effectiveness, Persistence Rates for Atopic Dermatitis Therapy
08/13/2020
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...
Jonathan Silverberg, MD, PhD, MPH, associate professor of dermatology at The George Washington University School of Medicine and Health Sciences, Washington, DC, offers insight into his real-world data study in which he and his colleagues...
Jonathan Silverberg, MD, PhD,...
08/13/2020
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
High Prevalence of Overlooked Demodex Blepharitis: Unraveling the Challenges in Diagnosis and Treatment
10/03/2023
Danielle Sposato
A comprehensive review of over 1,000 case records from 6 eye clinics revealed that Demodex blepharitis was prevalent in 57.7% of patients, regardless of their primary reason for the visit, aligning with similar rates reported in studies...
A comprehensive review of over 1,000 case records from 6 eye clinics revealed that Demodex blepharitis was prevalent in 57.7% of patients, regardless of their primary reason for the visit, aligning with similar rates reported in studies...
A comprehensive review of over...
10/03/2023
First Report Managed Care
Quiz
CDI Risk Factors
10/23/2023
What is the primary risk factor for Clostridioides difficile infection?
What is the primary risk factor for Clostridioides difficile infection?
What is the primary risk factor...
10/23/2023
First Report Managed Care
News
Bimekizumab is Safe and Effective in Treating Patients With Psoriatic Arthritis Native to Biologic Treatment, Study Finds
11/15/2023
Lisa Kuhns, PhD, MD
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients receiving bimekizumab met the primary endpoint of 50% improvement in the American College of Rheumatology response criteria (ACR50) compared with 10% of those receiving placebo.
At week 16, 44% of patients...
11/15/2023
First Report Managed Care
News
Managing Treatment Burden in PsA and RA: Patients' Views on Methotrexate and TNFi Use
12/15/2023
Hannah Musick
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide range of burden associated with treatments used for PsA and RA,” said researchers.
“Patients experience a wide...
12/15/2023
First Report Managed Care
News
CMS Announces Increased Participation in ACO Initiatives to Improve Care for Medicare Patients
02/02/2024
Hannah Musick
The Centers for Medicare & Medicaid Services (CMS) has announced increased participation and investment in accountable care organization (ACO) initiatives to improve the quality of care for patients with Medicare and address disparities in...
The Centers for Medicare & Medicaid Services (CMS) has announced increased participation and investment in accountable care organization (ACO) initiatives to improve the quality of care for patients with Medicare and address disparities in...
The Centers for Medicare &...
02/02/2024
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use